Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
1
Oxford Technology
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Brinter51-200 employees
Brinter is 3D bioprinting regenerative implants for the $1T tissue repair market. We develop bio-inductive, fully resorbable implants…
Secretome TherapeuticsSeries A $30M · 4 mo ago • Founded 2018 • 11-50 employees • 3 roles
Developing Novel Therapies from Neonatal Cardiac Progenitor Cells. Consistent, potent, and scalable neonatal cell sources designed for…
ExthymicVenture round $10.2M · 2 yr ago • Founded 2023 • 51-200 employees • 2 roles
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
TreeFrog TherapeuticsVenture round $32.4M · 16 mo ago
TreeFrog Therapeutics develops transformative regenerative medicine at industrial scale, enabling cell therapies to treat millions of…
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.

Overview

Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health of gastrointestinal (GI) tissues, intervening early in disease development to prevent colorectal cancer and treat inflammatory bowel disease (IBD).